Evidence map›Paper›PMID 37693206›Full record

ArticleRadiology. Cardiothoracic imaging2023

Multimodality Imaging of Cardiac Paragangliomas.

João G Carvalho, Johannes M I H Gho, Ricardo P J Budde, Johannes Hofland, Alexander Hirsch

Open access · greenAbstract read
In one paragraph

Article in Radiology. Cardiothoracic imaging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Cardiac Cavernous Hemangioma.JACC. Case reports · 2025
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

João G CarvalhoFrom the Department of Radiology and Nuclear Medicine (J.G.C., J.M.I.H.G., R.P.J.B., A.H.) and Department of Cardiology (J.M.I.H.G., R.P.J.B., A.H.), Erasmus MC, University Medical Center Rotterdam, Dr Molewaterplein 40, 3015 GD Rotterdam, the Netherlands; and Department of Internal Medicine, Sector Endocrinology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands (J.H.).ORCID https://orcid.org/0000-0002-6213-5854
Johannes M I H GhoFrom the Department of Radiology and Nuclear Medicine (J.G.C., J.M.I.H.G., R.P.J.B., A.H.) and Department of Cardiology (J.M.I.H.G., R.P.J.B., A.H.), Erasmus MC, University Medical Center Rotterdam, Dr Molewaterplein 40, 3015 GD Rotterdam, the Netherlands; and Department of Internal Medicine, Sector Endocrinology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands (J.H.).
Ricardo P J BuddeFrom the Department of Radiology and Nuclear Medicine (J.G.C., J.M.I.H.G., R.P.J.B., A.H.) and Department of Cardiology (J.M.I.H.G., R.P.J.B., A.H.), Erasmus MC, University Medical Center Rotterdam, Dr Molewaterplein 40, 3015 GD Rotterdam, the Netherlands; and Department of Internal Medicine, Sector Endocrinology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands (J.H.).ORCID 0000-0003-3792-615X
Johannes HoflandFrom the Department of Radiology and Nuclear Medicine (J.G.C., J.M.I.H.G., R.P.J.B., A.H.) and Department of Cardiology (J.M.I.H.G., R.P.J.B., A.H.), Erasmus MC, University Medical Center Rotterdam, Dr Molewaterplein 40, 3015 GD Rotterdam, the Netherlands; and Department of Internal Medicine, Sector Endocrinology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands (J.H.).
Alexander HirschFrom the Department of Radiology and Nuclear Medicine (J.G.C., J.M.I.H.G., R.P.J.B., A.H.) and Department of Cardiology (J.M.I.H.G., R.P.J.B., A.H.), Erasmus MC, University Medical Center Rotterdam, Dr Molewaterplein 40, 3015 GD Rotterdam, the Netherlands; and Department of Internal Medicine, Sector Endocrinology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands (J.H.).ORCID 0000-0002-3315-2006
Erasmus MC · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Paragangliomas are rare neuroendocrine tumors of extra-adrenal autonomic paraganglia origin. Paragangliomas rarely involve the heart, and they account for less than 1% of primary cardiac tumors. Most cardiac paragangliomas are incidentally detected at echocardiography or CT or during the workup of symptomatic patients with high catecholamine levels. Paragangliomas are typically located around the great vessels, coronary arteries (atrioventricular groove), or the atria, which can be explained by the tumor origin from the paraganglia and the distribution of the cardiac plexus. At MRI, cardiac paragangliomas typically have low to intermediate signal on T1-weighted images and high signal on T2-weighted images. The tumors are strongly vascularized, with high uptake on first-pass perfusion images and a heterogeneous pattern on late gadolinium enhancement images. Functional imaging is indicated for diagnostic confirmation and to screen for additional tumor locations or metastatic disease. Surgical excision is the only curative treatment. Cardiac CT angiography or invasive angiography should be performed preoperatively to precisely delineate tumor vascularization. In particular, its relation with the coronary arteries should be determined, as paragangliomas can be perfused by the coronary arteries, posing additional surgical challenges and the need for coronary revascularization. This imaging essay reviews the characteristics of paragangliomas and the use of multimodality imaging for diagnosis and treatment.

Indexed as

CardiacCT AngiographyHeartMolecular ImagingMR ImagingNeoplasms-PrimaryPET/CT

Identifiers

PMID37693206
PMCPMC10483254
OpenAlexW4385738257

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.